IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway
- 1 October 2016
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 78, 155-163
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (81172494)
This publication has 34 references indexed in Scilit:
- IL-27 induces the expression of IDO and PD-L1 in human cancer cellsOncotarget, 2015
- IFN-γ-induced IL-27 and IL-27p28 expression are differentially regulated through JNK MAPK and PI3K pathways independent of Jak/STAT in human monocytic cellsImmunobiology, 2014
- The antitumor potential of Interleukin-27 in prostate cancerOncotarget, 2013
- The IL-18 Antagonist IL-18–Binding Protein Is Produced in the Human Ovarian Cancer MicroenvironmentClinical Cancer Research, 2013
- Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivoLeukemia, 2011
- Interleukin-27 Acts as Multifunctional Antitumor Agent in Multiple MyelomaClinical Cancer Research, 2010
- IL-27 inhibits the development of regulatory T cells via STAT3International Immunology, 2007
- Expression of IL‐27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animalsInternational Journal of Cancer, 2005
- Potent Antitumor Activity of Interleukin-27Cancer Research, 2004
- Interleukin-12 in anti-tumor immunity and immunotherapyCytokine & Growth Factor Reviews, 2002